Thrombosis and Haemostasis

Article	Citations
COVID-19 Patients Putting on the Brakes with PAR1 Autoantibodies	122
	116
	104
Commentary: “No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study”	103
High anti-ADAMTS13 IgG Levels after Plasma Exchange Predict Delayed ADAMTS13 Normalization in Immune-mediated Thrombotic Thrombocytopenic Purpura	100
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation	83
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis	70
	69
Staying on Track: Collagen Fibers Orientation Strongly Affects Thrombi Formation at High Shear	55
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2	54
Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation	53
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban	47
Venous Thrombosis Associated with Different Types of SARS-CoV-2 Vaccines in the Netherlands—Results of the TERA Case-Control Study	46
Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction	35
Transient Platelet Hyporesponsiveness in Nonischemic Arrhythmogenic Cardiac Arrest After Achieving Restoration of Spontaneous Circulation in Pigs	32
Predictors, Incidence, and Proximal Extension Rate of Distal Deep Vein Thrombosis in Internal Medicine Wards: Insights from the AURELIO Study	30
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China	30
	30
Circulating Levels of Low-Density Granulocytes and Cell-Free DNA as Predictors of Cardiovascular Disease and Bone Deterioration in SLE Patients	27
	27
Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment	25
The Effect of Increasing Factor X Levels on Emicizumab-Driven Coagulation Potential	25
Reflections on World Thrombosis Day 2024	23
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”	23
Methoxyflurane Instead of Morphine in Acute Coronary Syndrome Patients: Results of the Randomized Controlled METHANE-SIRIO 4 Study	23

Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?	23
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	22
Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool	22
Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances	22
De Ritis Ratio and Heparin Therapy in Sepsis-Associated Liver Injury: A Multicenter Cohort Study	21
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	21
Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review	21
Perioperative Management of Patients Receiving Factor XI Inhibitors	21
Are More Patients with Thromboembolic Disease Dying Now Than Before?	19
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis	19
Longitudinal In Vivo Monitoring of Atheroprogression in Hypercholesterolemic Mice Using Photoacoustic Imaging	19
Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?	19
Volume Regulation and Nonosmotic Volume of Individual Human Platelets Quantified by High-Speed Scanning Ion Conductance Microscopy	19
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study	19
Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade	19
Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model	18
Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders	18
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials	17
Approach to Optimizing Tranexamic Acid Use in Trauma: Potential Utilization of Trauma Phenotypes	17
Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the European Society of Cardiology Classification	17
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia	16
Dual Antiplatelet Therapy or Dual Pathway Inhibition	15
Inherited Thrombophilia as a Risk Factor for Persistent Left Ventricular Thrombus Following Acute Myocardial Infarction	15
Rivaroxaban Treatment Prevents Atrial Myocyte Hypertrophy in Goats with Persistent Atrial Fibrillation by Inhibition of Protease-Activated Receptor-1	15
Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism	15
Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists—a Nationwide Linked-data Dutch Study	15
Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis	15
Optimal Detection of Atrial Fibrillation in Transient Ischaemic Attack: Rationale and design of the ODEA-TIA trial	14
Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding	14
Plasminogen Activator Inhibitor-1 Controls Mitochondrial Oxidative Stress in Vascular Smooth Muscle Cells and Coronary Arteries	14
Sensitivity to Aortic Rupture in Hereditary Aortic Diseases	14
Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis	14
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level	14
	14
Pulmonary Thromboembolism after Catheter Ablation of Cardiac Arrhythmias	13
Emerging Thrombotic Disorders Associated with Virus-Based Innovative Therapies: From VITT to AAV Gene Therapy–Related Thrombotic Microangiopathy	13
Novel Immunochromatographic Test for Anti-factor XIII B Subunit Autoantibodies to Diagnose Autoimmune Acquired Factor XIII Deficiency	13
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production	13
N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity	13
Additional Factor X Enhances Emicizumab-Driven Coagulation Function in Patients with Hemophilia A and Hemophilia A Mice	13
The Prognostic Value of the Age–D-Dimer–Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention	13
Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients	13
Transfer RNAs are Linked to Ischemic Stroke and Major Bleeding in Patients with End-Stage Kidney Disease	13
CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear	12
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both?	12
Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	12
Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases	12
Thrombosis and Haemostasis 2022 Editors' Choice Papers	12
Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study	12
	12

Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease	12
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer	11
Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation	11
	11
Characterization of Arteriovenous Thrombus Formation and Propagation in a Mouse Arteriovenous Fistula Model	11
Extravascular Binding of Coagulation Factor IX Gives Hemostasis a Boost	11
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19	11
Cryofibrinogen—Characteristics and Association with Cryoglobulin: A Retrospective Study Out of a Series of 1,712 Samples over 7 Years	11
Platelet-Leukocyte Aggregates: Targeting the Crosstalk	11
Diabetic Microvascular Disease and Risk of Peripheral Artery Disease, Foot Ulcer, Leg Infection, and Amputation	11
Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	11
Risk Factors for Venous Thromboembolism in Women of Childbearing Age	11
Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention	11
	10
Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII	10
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together	10
SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia	10
Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic Leukemia	10
	10
Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?	10
Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations	10
Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis	9
Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project	9
Activation of the Acute-Phase Response in Hemophilia	9
Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?	9
Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin	9
Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study	9
Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling Pathway	9
Digital Twins for Predictive Modelling of Thrombosis and Stroke Risk: Current Approaches and Future Directions	9
Physical and Mechanobiological Basis of Biological Functions of Platelets	9
Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters	9
Landscape and Spectrum of VWF Variants in Type 2 Von Willebrand Disease: Insights from a German Patient Cohort	9
The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction	8
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial	8
Compromised PAR1 Activation—A Cause for Bleeding in XMEN?	8
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype	8
Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study)	8
Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study	8
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study	8
Unveiling the Genetic Landscape of Inherited Primary Hemostasis Disorders by Whole-Exome Sequencing: Insights from a Multicenter Study	8
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved	8
Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis	8
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)	8
	8
High-Resolution Spatial Profiling Unveils Cellular Heterogeneity in Murine Atherosclerosis	8
Ischemic Stroke Burden Attributable to Household Air Pollution in WHO Regions from 1990 to 2021	8
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders	8
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry	8
	8
Human Platelets Internalize Pregnancy-Specific Glycoprotein-1 (PSG1)	8
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study	8
Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions	7
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	7
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases	7
Racial Differences in Bleeding Risks among Patients with Atrial Fibrillation: An Ecological Epidemiological Study Comparing Korea and UK Population	7
Navigating Anticoagulation in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac Magnetic Resonance Imaging	7
The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A	7
	7
Reply to the Comment: Revisiting Platelet-Associated Tissue Factor: Methodological Concerns in Flow Cytometry Detection: A Letter to the Editor	7
The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	7
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics	7
Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea	7
U-shaped Association of Third-trimester Serum Uric Acid with Postpartum Hemorrhage: Statistical Mediation Effects of Hemoglobin, Fibrinogen, and D-dimer—A Multicenter Cohort Study	7
Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals	7
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects	7
	7
Title: Association of Anisocytosis with Platelet-Rich Thrombi and Stroke Recurrence in Patients Undergoing Thrombectomy	7
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis	7
Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study	7
Educational Attainment, Obesity, and Venous Thromboembolism. Is Only Matter of Weight?	7
Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion	7
Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice	7
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy	7
	7
Blood Levels and Composition of Leukocyte–Platelet Aggregates in Inflammatory Diseases of Various Etiologies	6
Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity	6
DOACs for Superficial Vein Thrombosis: Risks of Pooling RCTs and Observational Studies in Comparative Effectiveness	6
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study	6
	6
Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Su	6

Novel Insights into the Aortic Mechanical Properties of Mice Modeling Hereditary Aortic Diseases	6
Free Fatty Acids Link Residual Lipid and Thrombotic Risk via Impairment of Aspirin Antiplatelet Effects	6
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study	6
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease	6
De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?	6
	6
	6
Hyperfibrinolysis is Associated with Complement Activation Following Trauma	6
Trypsin Activates Human Platelets via Proteolytic Cleavage of Protease-Activated Receptor 4	6
Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type	6
	6
Platelet Aggregation Is Not Altered in Men with Aortic Aneurysms	6